Equities

MiMedx Group Inc

MDXG:NAQ

MiMedx Group Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)6.23
  • Today's Change0.05 / 0.81%
  • Shares traded452.79k
  • 1 Year change-20.64%
  • Beta1.9782
Data delayed at least 15 minutes, as of Sep 19 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue321268259
OPERATING EXPENSES
Cost of revenue total554843
Selling, general and admin. expenses, total210207196
Depreciation/amortization1.862.233.40
Unusual expense(income)5.18123.84
Other operating expenses, total------
Total operating expense284283264
Operating income37(15)(5.04)
Other, net(0.46)(0.41)(0.4)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes31(20)(10)
Provision for income taxes(37)0.210.25
Net income after taxes67(20)(10)
Minority interest------
Net income before extra. Items67(20)(10)
Total extraordinary items(9.21)(10)--
Net income58(30)(10)
Inc.avail. to common excl. extra. Items56(27)(16)
Inc.avail. to common incl. extra. Items47(37)(16)
EPS RECONCILIATION
Basic/primary weighted average shares116113110
Basic/primary eps excl. extra items0.48(0.23)(0.15)
Basic/primary eps incl. extra items0.40(0.33)(0.15)
Dilution adjustment6.47----
Diluted weighted average shares146113110
Diluted eps excl. extra items0.43(0.23)(0.15)
Diluted eps incl. extra items0.36(0.33)(0.15)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental6.154.624.24
SUPPLEMENTAL INCOME
Depreciation, supplemental2.713.394.36
Total special items5.18123.84
NORMALISED INCOME
Normalized income before taxes36(7.57)(6.19)
Effect of special items on income taxes1.814.261.35
Income tax excluding impact of special items(35)4.471.59
Normalized income after tax71(12)(7.79)
Normalized income avail. to common59(19)(14)
Basic normalized EPS0.51(0.16)(0.13)
Diluted normalized EPS0.45(0.16)(0.13)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.